Cargando…

Downregulation of B7-H4 suppresses tumor progression of hepatocellular carcinoma

B7-H4, as a member of the B7 superfamily, was overexpressed in various types of cancers. However, the effects of B7-H4 on the aggressiveness of HCC and the underlying mechanisms have not yet been fully explored. For this purpose, B7-H4 expression was detected by Flow cytometry and Western blotting,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Lijie, Xie, Lulu, Li, Minjing, Dai, Hanhan, Wang, Xia, Wang, Peiyuan, Zhang, Qiang, Liu, Wei, Hu, Xuemei, Zhao, Mingdong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6795893/ https://www.ncbi.nlm.nih.gov/pubmed/31619714 http://dx.doi.org/10.1038/s41598-019-51253-2

Ejemplares similares

MARCH1 encourages tumour progression of hepatocellular carcinoma via regulation of PI3K‐AKT‐β‐catenin pathways
por: Xie, Lulu, et al.
Publicado: (2019)

Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway
por: Xie, Lulu, et al.
Publicado: (2019)

Resveratrol inhibits the malignant progression of hepatocellular carcinoma via MARCH1-induced regulation of PTEN/AKT signaling
por: Dai, Hanhan, et al.
Publicado: (2020)

Aberrant expression of B7-H4 may contribute to the development of hepatocellular carcinoma
por: Yuan, Lingling, et al.
Publicado: (2016)

Sinomenine Suppresses Development of Hepatocellular Carcinoma Cells via Inhibiting MARCH1 and AMPK/STAT3 Signaling Pathway
por: Yang, Wei, et al.
Publicado: (2021)

Downregulation of CENPK suppresses hepatocellular carcinoma malignant progression through regulating YAP1
por: Wang, Jianlin, et al.
Publicado: (2019)

Downregulated lncRNA SNHG18 Suppresses the Progression of Hepatitis B Virus-Associated Hepatocellular Carcinoma and Meditates the Antitumor Effect of Oleanolic Acid
por: Song, Wenqi, et al.
Publicado: (2022)

FOXK2 downregulation suppresses EMT in hepatocellular carcinoma
por: Kong, Jian, et al.
Publicado: (2020)

miR-202 Suppresses Hepatocellular Carcinoma Progression via Downregulating BCL2 Expression
por: Zhuang, Donghai, et al.
Publicado: (2020)

Downregulation of CENPK Suppresses Hepatocellular Carcinoma Malignant Progression through Regulating YAP1 [Corrigendum]
Publicado: (2022)

LukS-PV Inhibits Hepatocellular Carcinoma Progression by Downregulating HDAC2 Expression
por: Wang, Ziran, et al.
Publicado: (2020)

LukS-PV Inhibits Hepatocellular Carcinoma Progression by Downregulating HDAC2 Expression
por: Wang, Ziran, et al.
Publicado: (2020)

Downregulation of B7-H4 in the MHCC97-H hepatocellular carcinoma cell line by arsenic trioxide
por: CUI, LIMING, et al.
Publicado: (2016)

RRAD suppresses the Warburg effect by downregulating ACTG1 in hepatocellular carcinoma
por: Yan, Yingcai, et al.
Publicado: (2019)

Downregulation of SETD5 Suppresses the Tumorigenicity of Hepatocellular Carcinoma Cells
por: Park, Mijin, et al.
Publicado: (2022)

Loss of KLF4 and Consequential Downregulation of Smad7 Exacerbate Oncogenic TGF-β Signaling in and Promote Progression of Hepatocellular Carcinoma
por: Sun, Hongcheng, et al.
Publicado: (2017)

Protein kinase N1 promotes proliferation and invasion of liver cancer
por: Wang, Xia, et al.
Publicado: (2021)

B7-H4 overexpression is essential for early hepatocellular carcinoma progression and recurrence
por: Kang, Fu-Biao, et al.
Publicado: (2017)

Downregulation of microRNA-132 indicates progression in hepatocellular carcinoma
por: Zhang, Xin, et al.
Publicado: (2016)

miR-211 suppresses hepatocellular carcinoma by downregulating SATB2
por: Jiang, Guixing, et al.
Publicado: (2015)

Corrigendum to: Downregulation of SETD5 Suppresses the Tumorigenicity of Hepatocellular Carcinoma Cells
por: Park, Mijin, et al.
Publicado: (2022)

Atorvastatin-induced senescence of hepatocellular carcinoma is mediated by downregulation of hTERT through the suppression of the IL-6/STAT3 pathway
por: Wang, Sin-Ting, et al.
Publicado: (2020)

Myricetin Suppresses the Propagation of Hepatocellular Carcinoma via Down-Regulating Expression of YAP
por: Li, Minjing, et al.
Publicado: (2019)

PSMD7 downregulation suppresses lung cancer progression by regulating the p53 pathway
por: Xu, Xinchun, et al.
Publicado: (2021)

Numb downregulation suppresses cell growth and is associated with a poor prognosis of human hepatocellular carcinoma
por: XIE, CHENGZHI, et al.
Publicado: (2015)

MicroRNA-552 promotes hepatocellular carcinoma progression by downregulating WIF1
por: Li, Chao, et al.
Publicado: (2018)

ShRNA-Targeted COMMD7 Suppresses Hepatocellular Carcinoma Growth
por: Zheng, Lu, et al.
Publicado: (2012)

ZNF521 which is downregulated by miR-802 suppresses malignant progression of Hepatocellular Carcinoma through regulating Runx2 expression
por: Yang, Nan, et al.
Publicado: (2020)

Inhibition of NEK7 Suppressed Hepatocellular Carcinoma Progression by Mediating Cancer Cell Pyroptosis
por: Yan, Zilong, et al.
Publicado: (2022)

Downregulation of Homeobox B7 Inhibits the Tumorigenesis and Progression of Osteosarcoma
por: Yang, Lei, et al.
Publicado: (2017)

Downregulation of histone methyltransferase SET8 inhibits progression of hepatocellular carcinoma
por: Wu, Jianhua, et al.
Publicado: (2020)

Decrease of 5-Hydroxymethylcytosine Is Associated with Progression of Hepatocellular Carcinoma through Downregulation of TET1
por: Liu, Chungang, et al.
Publicado: (2013)

MicroRNA-499 Suppresses the Growth of Hepatocellular Carcinoma by Downregulating Astrocyte Elevated Gene-1
por: Wang, Jing, et al.
Publicado: (2020)

Correction: ShRNA-Targeted COMMD7 Suppresses Hepatocellular Carcinoma Growth
por: Zheng, Lu, et al.
Publicado: (2019)

Suppression of Esophageal Squamous Cell Carcinoma Development by Mechanosensitive Protein Piezo1 Downregulation
por: Gao, Lu, et al.
Publicado: (2021)

MTA1 Promotes Hepatocellular Carcinoma Progression by Downregulation of DNA-PK-Mediated H1.2(T146) Phosphorylation
por: Li, Yu-Hui, et al.
Publicado: (2020)

Downregulation of TUSC3 promotes EMT and hepatocellular carcinoma progression through LIPC/AKT axis
por: Deng, Ruxia, et al.
Publicado: (2022)

Interference of EFNA4 suppresses cell proliferation, invasion and angiogenesis in hepatocellular carcinoma by downregulating PYGO2
por: Yuan, Weidong, et al.
Publicado: (2022)

Correction to “Suppression of Esophageal Squamous Cell Carcinoma Development by Mechanosensitive Protein Piezo1 Downregulation”
por: Gao, Lu, et al.
Publicado: (2021)

Alantolactone inhibits cervical cancer progression by downregulating BMI1
por: Sun, Xiaodong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eefg3bl74c6pca4bnjp4kg99h1